Loading patent…
AssigneeOmniox.Inc.
InventorsStephen P.L. Cary, Natacha Le Moan, Ana Krtolica, Jonathan A. Winger
Estimating the term…
Described herein are methods for treating cardiovascular and pulmonary conditions, e.g., those associated with hypoxia, or treating a subject undergoing cardiac or respiratory arrest or cardiopulmonary resuscitation, using an H-NOX protein (or a mixture of H-NOX proteins), or using a combination of an H-NOX protein (or a mixture of H-NOX proteins) and a catecholamine (such as epinephrine or norepinephrine). Also described are compositions comprising an H-NOX protein (or a mixture of H-NOX proteins) and a catecholamine (such as epinephrine or norepinephrine).
A method for treating a cardiovascular disorder or pulmonary disorder in a subject in need thereof, said method comprising administering to the subject (a) an H-NOX protein;
(canceled)
6-8. (canceled)
(canceled)
(canceled)
20-21. (canceled)
24-25. (canceled)
A pharmaceutical composition comprising (i) an H-NOX protein or a mixture of H-NOX protein, and (ii) a catecholamine.
A method for treating a cardiovascular disorder or pulmonary disorder in a subject in need thereof, said method comprising administering to the subject an H-NOX protein.
29-50. (canceled)
52-71. (canceled)
73-77. (canceled)
Dependencies are inferred from the claim text.